Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India

Background: Patients with first-line drug resistance (DR) to rifampicin (RIF) or isoniazid (INH) as a first-line (FL) line probe assay (LPA) were subjected to genotypic DST using second-line (SL) LPA to identify SL-DR (including pre-XDR) under the National TB Elimination Program (NTEP), India. SL-DR...

Descripción completa

Detalles Bibliográficos
Autores principales: Gopalaswamy, Radha, Palani, Nandhini, Viswanathan, Dinesh, Preysingh, Bershila, Rajendran, Suchithra, Vijayaraghavan, Vaishnavee, Thangavel, Kannadasan, Vadivel, Senthil Devi, Stanley, Hannah, Thiruvengadam, Kannan, Jayabal, Lavanya, Murugesan, Kaleeswari, Rathinam, Sridhar, Frederick, Asha, Sivaramakrishnan, Gomathi, Padmapriyadarsini, Chandrasekaran, Shanmugam, Sivakumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303903/
https://www.ncbi.nlm.nih.gov/pubmed/37374209
http://dx.doi.org/10.3390/medicina59061005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303903/
https://www.ncbi.nlm.nih.gov/pubmed/37374209
http://dx.doi.org/10.3390/medicina59061005

Ejemplares similares